Skip to main content
. 2022 Jul 29;13:949413. doi: 10.3389/fimmu.2022.949413

Figure 1.

Figure 1

Soluble IFNAR2 (sIFNAR2) plasma levels of severe COVID-19 patients (n = 347) divided into non-survivor (n = 108, yellow dots) and survivor (n = 239, purple dots). sIFNAR2 level was evaluated by ELISA. Statistical comparison was performed using Mann-Whitney U Test, p < 0.05.